Press releases 2020/21

14.10.2021 – Ethypharm consolidates its European presence with the integration of Altan, now led by Manuel Casegas as its General Manager

21.06.2021 – Ethypharm to acquire Altan Pharma, entering the Spanish market and enhancing its Critical Care portfolio and R&D pipeline

19.05.2021 – Ethypharm reinforces its late-stage R&D pipeline with a novel acute treatment of migraine 

06.05.2021 – Hélène Moore appointed Head of Ethypharm Digital Therapy with responsibility for building a European Leader in this innovative field.

23.04.2021 – Ethypharm establishes direct presence in Italy

17.03.2021 – Ethypharm partners with Clever Leaves for medical cannabis products in Germany

22.01.2021 – ORPHELIA Pharma und Ethypharm unterzeichnen eine Lizenzvereinbarung für die Entwicklung und Vermarktung von Kigabeq® in China (EN: ORPHELIA Pharma and Ethypharm sign a licensing agreement for the development and commercialisation of Kigabeq® in China)

24.11.2020 – Ethypharm und CTRS unterzeichnen Partnerschaftsabkommen für die Zulassung und Vermarktung von Orphacol® in China (EN: Ethypharm and CTRS sign partnership agreement for the approval and marketing of Orphacol® in China)

19.11.2020 – Spezialpharmaunternehmen Ethypharm an Bord von The CommsDuo – Das Beraterteam unterstützt die Kommunikation in Deutschland (EN: Specialist pharmaceutical company Ethypharm on board of The CommsDuo – The team of consultants supports communications in Germany)

Media Contacts

Markus Gladbach,, +49 157 71 44 60 98

Christine Vogl-Kordick,, +49 172 86 50 982